Growth Metrics

Eli Lilly (LLY) Shares Outstanding (Weighted Average) (2016 - 2025)

Eli Lilly's Shares Outstanding (Weighted Average) history spans 17 years, with the latest figure at $897.3 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) changed 0.37% year-over-year to $897.3 million; the TTM value through Dec 2025 reached $897.3 million, changed 0.37%, while the annual FY2025 figure was $897.3 million, 0.37% changed from the prior year.
  • Shares Outstanding (Weighted Average) reached $897.3 million in Q4 2025 per LLY's latest filing, roughly flat from $896.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $908.8 million in Q1 2021 to a low of $896.9 million in Q3 2025.
  • Average Shares Outstanding (Weighted Average) over 5 years is $901.7 million, with a median of $900.8 million recorded in 2024.
  • Peak YoY movement for Shares Outstanding (Weighted Average): dropped 0.77% in 2022, then grew 0.13% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $907.0 million in 2021, then fell by 0.58% to $901.7 million in 2022, then decreased by 0.17% to $900.2 million in 2023, then grew by 0.04% to $900.6 million in 2024, then fell by 0.37% to $897.3 million in 2025.
  • Per Business Quant, the three most recent readings for LLY's Shares Outstanding (Weighted Average) are $897.3 million (Q4 2025), $896.9 million (Q3 2025), and $898.3 million (Q2 2025).